Publications by authors named "Barbara Bogacka"

Claim this Profile
A
A constrained optimum adaptive design for dose finding in early phase clinical trials.
M Iftakhar Alam, Barbara Bogacka, D Stephen Coad

J Biopharm Stat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model based dose personalization in clinical trials.
Kabir Soeny, Barbara Bogacka, Byron Jones

Comput Methods Programs Biomed· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trials.
Kabir Soeny, Barbara Bogacka, Byron Jones

Stat Methods Med Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined criteria for dose optimisation in early phase clinical trials.
M Iftakhar Alam, D Stephen Coad, Barbara Bogacka

Stat Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing dose regimens and fixed dose combination ratios in clinical trials.
Kabir Soeny, Barbara Bogacka, Byron Jones, Thomas Bouillon

J Biopharm Stat· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimum designs for non-linear mixed effects models in the presence of covariates.
Barbara Bogacka, Mahbub A H M Latif, Steven G Gilmour, Kuresh Youdim

Biometrics· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pancreatic cancer microenvironment].
Krzysztof Dąbkowski, Barbara Bogacka, Maciej Tarnowski, Teresa Starzyńska

Pol Merkur Lekarski· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimum design of experiments for enzyme inhibition kinetic models.
Barbara Bogacka, Maciej Patan, Patrick J Johnson, Kuresh Youdim, Anthony C Atkinson

J Biopharm Stat· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential application of D-optimal designs in the efficient investigation of cytochrome P450 inhibition kinetic models.
Kuresh A Youdim, Anthony C Atkinson, Maciej Patan, Barbara Bogacka, Patrick J Johnson

Drug Metab Dispos· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two design optimality criteria applied to a nonlinear model.
Barbara Bogacka, Francis Wright

J Biopharm Stat· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis